A generic product, VSL3, has yielded positive remission studies, as have the probiotic strains Lactobacillus casei and Lactobacillus rhamnosus
In some embodiments, a pulsed release profile is achieved by solubilizing up to 40% of the delivered dose of the therapeutic agent (e.g., micronized therapeutic agent, or free base or salt or prodrug thereof
It has no licensed medical indication in the UK
These injections are designed to provide a direct source of amino acids, which can be especially beneficial for individuals with deficiencies or specific health needs
Comparing Delivery Methods Understanding how nasal spray stacks up against other administration routes helps inform the best choice for individual needs: Injection (Subcutaneous/Intramuscular) Highest bioavailability (near 100%) Precise dosing control Requires injection supplies and technique Potential injection site reactions Less convenient for daily use Oral Capsules/Tablets Maximum convenience No special administration technique needed Poor bioavailability due to gastric degradation Inconsistent absorption First-pass liver metabolism Nasal Spray Good bioavailability (60-80% of injection) Rapid absorption Convenient and discreet Bypasses digestive degradation Requires proper spray technique May cause minor nasal irritation For many users, the best peptide retail US suppliers now offer nasal spray formulations that balance effectiveness with practical convenience
